Incyte (INCY) Stock Concentration Calculator
Calculator · free · no signup · INCYQuantify Incyte concentration risk. Drawdown impact at 30 / 50 / 70%, with the tax-aware trade-off between selling down and hedging.
Beta · invite-only · AlphaLatitude Inc. · Free Tools
Your inputs
Adjust — results update instantly.Position & portfolio
Tax
Most fee-only advisors target ≤10% in any single name. You're at 67%.
Estimates only. Not financial advice.
Most sensitive to: Expected market return (±10% on this input swings best-plan wealth by ±$190,508).
Cost of fully de-concentrating
All three plans sell to 0% (no hedge).Sensitivity. If your expected position return drops below 19.6%/yr, lump-sum (sell everything today) beats every spread plan above.
Have multiple RSU vest lots? The RSU Lot Order Calculator picks which lots to sell first, and on which dates, to divest at the lowest computed tax.
Build your own plan
Toggle below — chart updates live. Sell buttons show the slice.Tech / Software single names hit a 50%+ peak-to-trough drawdown in roughly 1 of every 5 rolling 3-year windows over 2014–2024. Even mega-caps aren’t exempt.
Tax brackets: 2026 · Estimates only — not financial advice.
Estate note. Heirs receive a stepped-up basis at death (§1014), eliminating built-in gain on inherited shares. Older holders who plan to bequeath rather than sell may rationally never de-concentrate.
You sized one position's risk. The beta integrates hedging, sell-down, and tax timing into one optimized plan.
Request beta access →Related calculators: Protect Your Stock Calculator · RSU Lot Order Calculator · Equity Funding Plan Calculator
About Incyte
Incyte (INCY) is a public Pharma/Biotech company, incorporated in Delaware and headquartered in Wilmington, DE.
Last close: $123.47 per share (as of 2026-08-18).
Equity grants at Incyte typically include restricted stock units (RSUs).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Source: Wikipedia (CC BY-SA 4.0)
The company built itself around Jakafi, a JAK inhibitor approved in 2011 for myelofibrosis and later for other conditions, which supplies most of its revenue. That concentration is the central fact of the investment case: the compound's patent life sets a deadline the pipeline has to beat. Research has extended into dermatology and additional oncology indications, some through partnerships that share development cost. Unlike larger peers, the company has neither the scale nor the cash to acquire its way out of a gap. Headquarters are in Wilmington, Delaware.
Sources: sec.gov · en.wikipedia.org
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Incyte.
If a meaningful share of your net worth sits in INCY, concentration risk is the question. This calculator quantifies drawdown impact at 30 / 50 / 70%, and the trade-off between selling down (tax cost now) versus hedging (option premium drag), auto-filled with INCY's option-implied volatility.
Example: 5,000 INCY shares at $123.47 is a $617,350 position. A 30% drawdown costs $185,205; a 50% drawdown costs $308,675; a 70% drawdown costs $432,145. The calculator quantifies the trade-off between selling down (immediate capital-gains tax) and hedging (option premium drag) using INCY's option-implied volatility and your cost basis.
All Incyte tools → · Use the generic Stock Concentration Calculator for any company. Diversifying multiple RSU lots? See the lot-by-lot sell order →
Incyte equity questions
- How much INCY stock is too much?
- There is no single threshold, but the larger the share of your net worth in one stock, the more a single bad year can set back your plans. The calculator above quantifies the drawdown impact at 30, 50, and 70 percent for your INCY position and weighs selling down (which triggers capital-gains tax now) against hedging (which costs option premium).
- Does Incyte grant ISOs, NSOs, or RSUs?
- Equity compensation at Incyte typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
Find another companyPharma/Biotech peers
One piece of the puzzle.
OptionsAhoy plans your Incyte equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.